From SBA-backed asset purchases to private equity rollover structures, here is how buyers and sellers in the medical aesthetics space can build deals that close — and hold up post-close.
Acquiring a med spa is not like buying a typical service business. The intersection of healthcare regulation, elective consumer spending, and high provider dependency creates a deal structuring environment that demands both financial creativity and regulatory precision. Most med spa acquisitions in the $1M–$5M revenue range fall into three structural categories: SBA 7(a)-financed asset purchases, private equity platform acquisitions with management rollover and earnouts, and CPOM-compliant structures using a Management Services Agreement to legally separate the medical practice entity from the business operations entity. Each approach carries distinct implications for how the purchase price is allocated, how the seller's deferred revenue liability is handled, how physician oversight is maintained post-close, and whether key providers will stay. Understanding the right structure for a given deal depends on the buyer's capital resources, the seller's dependency risk profile, the state's corporate practice of medicine laws, and the quality of the med spa's recurring revenue. This guide breaks down each structure type, provides realistic sample deal scenarios, and offers negotiation guidance specific to the nuances of medical aesthetics transactions.
Find Med Spa Businesses For SaleSBA 7(a) Asset Purchase
The most common structure for individual buyers and entrepreneurial operators acquiring a med spa in the lower middle market. The buyer uses an SBA 7(a) loan — typically up to $5M — to finance the acquisition of business assets including equipment, patient database, goodwill, brand, and vendor contracts. The medical entity is typically excluded from the asset purchase to comply with CPOM laws, with a separate Management Services Agreement governing the relationship between the new business entity and the licensed medical practice. A seller note of 5–10% is commonly layered in to bridge any valuation gap and align seller incentives during transition.
Pros
Cons
Best for: Individual buyers, entrepreneurial physicians or nurse practitioners, and first-time acquirers purchasing a single-location med spa with $300K–$700K EBITDA and a clean compliance history
Private Equity Platform Acquisition with Management Rollover and Earnout
Used by aesthetics-focused roll-up platforms and PE-backed dermatology or plastic surgery groups acquiring a profitable med spa as a platform add-on or tuck-in. The seller receives a cash-at-close payment representing 75–85% of total enterprise value, with the remaining 15–25% structured as rollover equity in the acquiring platform. An earnout tied to EBITDA growth over 24 months provides additional upside if the location hits performance targets. The seller typically retains a clinical or operational role for 12–24 months. This structure is particularly well-suited when the seller is not the primary injector and the business has strong systems, a tenured provider team, and a 200+ member recurring revenue base.
Pros
Cons
Best for: Owner-operators who are not the primary clinical provider, have a strong recurring revenue base, want partial liquidity now with equity upside, and are willing to stay engaged operationally for 12–24 months post-close
Asset Purchase with Management Services Agreement (MSA) Structure
Required in states with strict corporate practice of medicine laws — including California, Texas, New York, and others — this structure separates the business assets from the medical practice. The buyer acquires the management company, which owns all non-clinical assets such as equipment, brand, lease, and staff. A separately held professional corporation or medical practice entity — owned by a licensed physician — contracts with the management company via an MSA for business support services. The MSA governs revenue flow from the medical entity to the management company, ensuring the buyer captures economics while the physician entity maintains clinical independence. This is the most legally complex structure but is often the only compliant path in highly regulated states.
Pros
Cons
Best for: Non-physician buyers in CPOM-restricted states, PE platforms executing roll-up strategies across multiple states, and any acquisition where the seller's medical license cannot or will not transfer to a new owner
SBA 7(a) Acquisition — Nurse Practitioner-Owned Single Location, Midwest Suburban Market
$1,800,000
SBA 7(a) Loan: $1,260,000 (70%) | Seller Note: $270,000 (15%) | Buyer Equity Injection: $270,000 (15%)
10-year SBA loan at approximately 9.5–10.5% interest; seller note at 6% interest over 5 years with a 12-month standby period; seller remains engaged as a part-time clinical consultant for 90 days post-close; deferred revenue liability of $85,000 from pre-sold packages credited against purchase price at close; non-compete covering 25-mile radius for 3 years
PE Platform Add-On Acquisition — Physician-Owned Multi-Provider Med Spa, Southeast Affluent Suburb
$3,400,000
Cash at Close: $2,720,000 (80%) | Rollover Equity in Platform: $680,000 (20%) | Earnout: Up to $340,000 additional over 24 months if EBITDA exceeds $650,000 annually
Rollover equity valued at platform's most recent institutional funding round; earnout calculated on trailing 12-month EBITDA with mutually agreed add-backs defined at close; seller retains Clinical Director title for 18 months at market-rate compensation; working capital peg set at 60-day average; equipment refresh fund of $150,000 escrowed for laser device upgrade within 12 months post-close
MSA Structure Asset Purchase — California-Based Med Spa, Non-Physician Buyer
$2,200,000
Management Company Asset Purchase: $2,200,000 — financed via $1,540,000 SBA loan (70%), $330,000 seller note (15%), $330,000 buyer equity (15%); Medical entity remains with licensed physician under new MSA
MSA fee set at 8% of gross medical revenue flowing to physician-owned PC; management company retains all non-clinical revenue streams including retail skincare and membership fees; physician medical director compensated at $60,000 annually under separate employment agreement; MSA term of 10 years with mutual renewal options; buyer has right of first refusal if physician seeks to transfer medical entity ownership
Find Med Spa Businesses For Sale
Pre-screened targets ready for your deal structure — free to join.
Yes, most med spa acquisitions are SBA 7(a) eligible, provided the business meets SBA size standards, has at least 2 years of operating history, and the buyer can demonstrate management experience in healthcare or business operations. Lenders will scrutinize owner dependency closely — businesses where the seller is the sole injector face higher scrutiny and may require a larger equity injection or seller note to get approved. Lenders experienced in healthcare service businesses, particularly those with aesthetics or dental practice lending backgrounds, are better equipped to underwrite med spa deals and should be prioritized over generalist SBA lenders.
Corporate practice of medicine (CPOM) laws in many states prohibit non-physician entities from owning a medical practice or directly employing physicians. In the context of a med spa acquisition, this means a non-physician buyer cannot simply purchase the entire business as a single entity in CPOM-restricted states like California, Texas, and New York. Instead, the acquisition must be structured using a Management Services Agreement, where the buyer acquires the management company holding all non-clinical assets while a physician-owned professional entity retains ownership of the clinical practice. The MSA governs the economic relationship between the two entities. Buyers should engage a healthcare transactional attorney with CPOM expertise specific to the target state before signing any letter of intent.
A well-structured med spa earnout typically runs 12–24 months and is tied to EBITDA performance, with targets set 5–15% above the trailing 12-month EBITDA at time of close. The earnout should represent no more than 10–20% of total enterprise value, as larger earnout percentages create friction and incentive misalignment. Critically, both parties must agree in writing on exactly how EBITDA will be calculated — including which corporate overhead allocations, management fees, and one-time expenses are excluded. Earnouts work best when the seller is staying on in an active operational or clinical role; they are difficult to enforce fairly when the seller has fully exited the business.
Deferred revenue from pre-sold treatment packages and membership obligations is one of the most commonly mishandled items in med spa deals. These liabilities represent services the buyer will be obligated to deliver post-close without receiving payment, since the cash was already collected by the seller. The standard approach is to obtain a full schedule of outstanding package balances and membership obligations during due diligence, then credit the exact amount of that liability against the purchase price at close — dollar for dollar. Some deals structure this as a post-close working capital adjustment. Sellers should not expect to keep all pre-sold package revenue if those services have not yet been rendered, and buyers should insist on an independent audit of the deferred revenue balance before closing.
Med spa valuations in the lower middle market typically range from 3.5x to 6x EBITDA, depending on business quality, revenue predictability, and deal structure. A single-location spa where the owner is the primary injector and has no membership program will trade toward the lower end of that range — often 3.5x to 4x — due to transition risk and lack of recurring revenue. A multi-provider spa with 300+ active members, the owner not injecting, clean compliance history, and a prime location in a high-income market will command 5x to 6x. PE platform acquisitions for strong businesses can occasionally exceed 6x when strategic value — such as an anchor location in a new geography — is factored in. Multiple compression is real when provider dependency, deferred revenue liabilities, or compliance issues are discovered during diligence.
A Management Services Agreement is a contract between the business management company and the physician-owned medical entity that defines the terms under which the management company provides administrative, operational, and financial services to the practice in exchange for a management fee. In CPOM-compliant med spa acquisitions, the MSA is the legal mechanism that allows a non-physician buyer to capture the economics of the business without technically owning the medical practice. The MSA governs fee structures, decision-making authority, term and termination rights, and the scope of services. A poorly drafted MSA creates significant post-close risk — including disputes over fee calculations, loss of operational control, and regulatory exposure. Buyers should budget $15,000–$30,000 for experienced healthcare transaction counsel to draft or review the MSA as part of the deal.
More Med Spa Guides
More Deal Structure Guides
Find the right target, structure the deal, and close with confidence.
Create your free accountNo credit card required
For Buyers
For Sellers